Table 1 Demographic and clinical characteristics of the study groups
From: Is adiponectin associated with acute myocardial infarction in Iranian non obese patients?
Variable | Case group n = 43 | Control group n = 43 | P-value |
|---|---|---|---|
Age | 62.7 ± 13.3 | 62.1 ± 12.3 | 0.84 |
Male, n (%) | 29 (67.4%) | 24 (55.8%) | 0.27 |
BMI (kg/m2) | 22.3 ± 3 | 23.6 ± 3.15 | 0.44 |
Current smoker, n(%) | 10 (23.3%) | 4 (9.3%) | 0.14 |
HTN, n(%) | 9 (20.9%) | 14 (32.6%) | 0.33 |
Adiponectin (μg/mL) | 3.3 ± 1.7 | 5 ± 1.5 | < 0.001* |
Type 1 DM, n (%) | 2 (4.7%) | 4(9.3%) | 0.68 |
Type 2 DM, n (%) | 7(16.3%) | 4(9.3%) | 0.52 |
Total Cholesterol (mg/dL) | 189.3 ± 45.2 | 171.8 ± 33 | 0.05 |
LDL-C (mg/dL) | 113.7 ± 36.6 | 103.9 ± 28.7 | 0.13 |
HDL-C (mg/dL) | 46.7 ± 11.4 | 41.9 ± 9.5 | 0.05 |
LDL/HDL ratio | 4.23 | 4.24 | 0.96 |
Triglyceride (mg/dL) | 146 ± 99.6 | 144 ± 99.8 | 0.93 |
Serum creatinine (mg/dl) | 1 ± 0.1 | 1.1 ± 0.1 | 0.68 |